Literature DB >> 9332365

The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors.

L R Finger1, J Pu, R Wasserman, R Vibhakar, E Louie, R R Hardy, P D Burrows, L G Billips.   

Abstract

We report the complete cDNA sequence and the genomic structure of the human PD-1 homologue. An analysis of the expression pattern of the human PD-1 gene (hPD-1) and the murine PD-1 gene (mPD-1) in developing bone marrow B-lineage cells was also undertaken. The full length hPD-1 cDNA is 2106 nucleotides long and encodes a predicted protein of 288 amino acid residues. The hPD-1 and mPD-1 genes share 70% homology at the nucleotide level and 60% homology at the amino acid level. Four potential sites for N-linked glycosylation are conserved, as are a stretch of amino acids between two cysteine residues resembling a V-set immunoglobulin domain, and another region containing a motif similar to an immunoreceptor tyrosine-based inhibitory motif. Isolation of the genomic locus of the hPD-1 gene reveals that the gene is composed of five exons located on human chromosome 2 at band q37. The 5' flanking region lacks TATA and CAAT cis-acting elements, but includes a number of potential transcription factor binding sites and a dominant transcription start site. The mPD-1 gene was preferentially expressed in pro-B cells from murine adult bone marrow. Although hPD-1 was not preferentially expressed in pro-B cells from human fetal bone marrow, treatment of isolated pro-B cells with interleukin-7 resulted in a dramatic increase in expression. These data suggest that PD-1 may play a role in B-cell differentiation during the pro-B cell stage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9332365     DOI: 10.1016/s0378-1119(97)00260-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  30 in total

1.  One-pot system for synthesis, assembly, and display of functional single-span membrane proteins on oil-water interfaces.

Authors:  Peter J Yunker; Haruichi Asahara; Kuo-Chan Hung; Corey Landry; Laura R Arriaga; Ilke Akartuna; John Heyman; Shaorong Chong; David A Weitz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-31       Impact factor: 11.205

2.  Prokaryotic expression of the extracellular domain of porcine programmed death 1 (PD-1) and its ligand PD-L1 and identification of the binding with peripheral blood mononuclear cells in vitro.

Authors:  Yan-Ping Zhu; Feng Yue; Yong He; Peng Li; Yuan Yang; Yu-Ting Han; Yan-Fang Zhang; Guo-Peng Sun; Dong-Guang Guo; Mei Yin; Xuan-Nian Wang
Journal:  Can J Vet Res       Date:  2017-04       Impact factor: 1.310

Review 3.  Sequence, structure, function, immunity: structural genomics of costimulation.

Authors:  Kausik Chattopadhyay; Eszter Lazar-Molnar; Qingrong Yan; Rotem Rubinstein; Chenyang Zhan; Vladimir Vigdorovich; Udupi A Ramagopal; Jeffrey Bonanno; Stanley G Nathenson; Steven C Almo
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 4.  Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation.

Authors:  Laura L Carter; Beatriz M Carreno
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

5.  Tumor-Localized Secretion of Soluble PD1 Enhances Oncolytic Virotherapy.

Authors:  Mee Y Bartee; Katherine M Dunlap; Eric Bartee
Journal:  Cancer Res       Date:  2017-03-17       Impact factor: 12.701

6.  Polymorphisms in programmed death-1 gene are not associated with chronic HBV infection in Chinese patients.

Authors:  Feng Lv; Yu-Feng Gao; Zhen-Huan Zhang; Tian-Chen Zhang; Fa-Ming Pan; Ming-Fang Cui; Shu-Ling Xia; Xu Li; Hua-Fa Yin
Journal:  World J Hepatol       Date:  2011-03-27

Review 7.  A Critical Insight into the Clinical Translation of PD-1/PD-L1 Blockade Therapy in Clear Cell Renal Cell Carcinoma.

Authors:  Caroline E Nunes-Xavier; Javier C Angulo; Rafael Pulido; José I López
Journal:  Curr Urol Rep       Date:  2019-01-15       Impact factor: 3.092

Review 8.  [Mode of action, new targets and potential biomarkers in modern immunotherapy].

Authors:  J Bedke; V Stühler; T Todenhöfer; A Stenzl
Journal:  Urologe A       Date:  2018-11       Impact factor: 0.639

9.  Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies.

Authors:  Dharambir K Sanghera; Susan Manzi; Franklin Bontempo; Cara Nestlerode; M Ilyas Kamboh
Journal:  Hum Genet       Date:  2004-08-18       Impact factor: 4.132

Review 10.  B7-H1 pathway and its role in the evasion of tumor immunity.

Authors:  Haidong Dong; Lieping Chen
Journal:  J Mol Med (Berl)       Date:  2003-04-30       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.